Agreement signedPublished 14 Jun 2023

Blue Water Biotech, Inc. /
WraSer, LLC and Xspire Pharma, LLC

Blue Water Biotech to buy WraSer pharmaceutical assets

Terms
Not stated
Stage
Agreement signed
Buy side: Blue Water Biotech, Inc.
Buy sideBlue Water Biotech, Inc.
Target: WraSer, LLC and Xspire Pharma, LLC
TargetWraSer, LLC and Xspire Pharma, LLC
Source · 14 Jun 2023
Buy side: Blue Water Biotech, Inc.
Buy sideBlue Water Biotech, Inc.
Target: WraSer, LLC and Xspire Pharma, LLC
TargetWraSer, LLC and Xspire Pharma, LLC
01 / BuyerBlue Water Biotech, Inc.
02 / TargetWraSer, LLC and Xspire Pharma, LLC
01

What happened

Blue Water Biotech, Inc. entered into an asset purchase agreement with WraSer, LLC and Xspire Pharma, LLC for six FDA-approved pharmaceutical assets across several indications, including cardiology, otic infections and pain management.

The stated consideration includes cash payments, 1.0 million shares of common stock and an additional cash payment one year after the closing date.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Blue Water Biotech to buy WraSer pharmaceutical assets

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.